Vimarsana
Biggest News Aggregation in the World

Page 4 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP) - Vimarsana News

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP)

StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report published on Thursday. The firm issued a buy rating on the stock. A number of other brokerages have also commented on MEIP. TheStreet cut shares of MEI Pharma from a c- rating to a d+ rating in a report on […]

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report released on Thursday. The brokerage issued a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. Stifel Nicolaus reiterated a hold rating and set a $7.00 price target on shares of MEI […]

IRLAB Therapeutics: IRLAB Appoints Kristina Torfgård as New CEO - Vimarsana News

IRLAB Therapeutics: IRLAB Appoints Kristina Torfgård as New CEO

GOTHENBURG, SE / ACCESSWIRE / May 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden. May 27, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) - a company discovering and

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research note published on Thursday morning. The brokerage issued a buy rating on the stock. A number of other equities research analysts have also recently commented on MEIP. TheStreet cut shares of MEI Pharma from a c- rating to a d+ […]

Hookipa Pharma's (HOOK) "Outperform" Rating Reaffirmed at Royal Bank of Canada - Vimarsana News

Hookipa Pharma's (HOOK) "Outperform" Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a report published on Tuesday morning, Benzinga reports. The firm currently has a $5.00 price target on the stock. Separately, HC Wainwright reduced their target price on shares of Hookipa Pharma from $6.50 to $5.00 and set […]